Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa Gene Transfer Clinical Trial for Variant Late Infantile Neuronal Ceroid Lipofuscinosis, Delivering the CLN6 Gene by Self-Complementary AAV9

NCT02725580 is registered in ClinicalTrials.gov with Emily de los Reyes as lead sponsor.

NCT NCT02725580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02725580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa Gene Transfer Clinical Trial for Variant Late Infantile Neuronal Ceroid Lipofuscinosis, Delivering the CLN6 Gene by Self-Complementary AAV9
Lead sponsor
Emily de los Reyes
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2016
Completion date
October 31, 2024
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

variant late-infantile neuronal ceroid lipofuscinosis